Clinical-grade preventive intelligence
BioTwin equips primary care and frontline clinics with AI-powered screening protocols to support medical decision and stratify risk across 5 clinical domains and 15 health conditions. From simple at-home collection.
Patients join the journey through TwinMe, our consumer app for personalized health tracking.
BioTwin multi-omics approach integrates biological analysis, complete lifestyle & medical data into actionable clinical insights — enabling screening, longitudinal monitoring, and decision support.
Current healthcare often intervenes too late, treats populations instead of individuals, and leaves prevention to chance.
No unified protocol covers multiple disease domains at once. Clinicians juggle disconnected screening tools with no shared view.
People only engage the system when symptoms appear. By then, early intervention windows have closed.
Comprehensive screening programs are expensive, time-consuming, and hard to repeat. Most clinics can't offer it at scale.
BioTwin integrates multi-omics data and AI-driven risk models, and a simple at-home collection protocol to give clinicians a unified view of patient health across 15 conditions.
AI-powered screening protocols, unified dashboards, longitudinal monitoring, and structured triage support across 5 domains.
Through TwinMe, patients access their health data, track their progress, and stay connected to their care team.
BioTwin is designed as a clinical decision-support (CDST) layer that augments physician judgment with longitudinal, multi-omic insights. It does not replace clinicians or provide standalone diagnoses.
5 clinical domains. 15 health conditions.
BioTwin protocol monitors biological signals, screens for meaningful deviations from each individual's baseline, and flags risk supporting clinical, triage and routing decisions. BioTwin does not replace physicians. BioTwin provides a longitudinal decision-support layer that strengthens primary-care workflows and reduces uncertainty, latency and diagnostic burden.
Helps flag early biological risk, including where no screening exists
Helps refine imaging, biopsy, and referral prioritization
Helps support surveillance and recurrence monitoring decisions
Helps identify early biological risk before overt symptoms
Helps support specialist referral and diagnostic triage pathways
Helps monitor progression and treatment response longitudinally
Helps flag elevated risk before acute events or decompensation
Helps support referral, imaging, and therapy optimization decisions
Helps monitor biological response to treatment over time
Track hidden metabolic and performance decline early
Personalize intervention intensity before complications emerge
Track whether lifestyle and therapy changes actually work
Extends healthspan through continuous trajectory optimization
Detects early multi-system decline before disease onset
Converts biological drift into proactive longevity action
Clinical decision support tool — not a diagnostic replacement.
The BioTwin 5-10-15 Protocol delivers a comprehensive biological scan of you, powered by your personal virtual twin. It combines multi-omic analysis (genomic, proteomic, metabolomic biomarkers), clinical and lifestyle assessments, and continuous data from wearables, apps, imaging, and medical records, alongside facial, skin, voice, and movement biomarkers. All signals are unified into a continuously updated virtual twin, providing a 360-degree view of your health and how it evolves over time, not a one-time snapshot. 5 days. 10 drops. 15 monitored areas.
Simple & effortless samples collection over 5 days, flexible to fit your schedule and capture biological variability.
Low-friction at-home collection using finger blood, urine, and saliva. No clinic visit required.
One unified view across five clinical domains: Oncology, Neurology, Cardiology, Lifestyle, and Longevity.
Prepare for 2027 deployment
Limited onboarding slots for primary-care partners
Begin collecting your biological baseline now. Protocol activation in 2027.